RABEPRAZOLE SODIUM
These highlights do not include all the information needed to use RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS. RABEPRAZOLE sodium delayed-release tablets, for oral useInitial U.S. Approval: 1999
c837a391-cb1c-4170-8b90-f42c152cbce0
HUMAN PRESCRIPTION DRUG LABEL
Mar 22, 2019
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
RABEPRAZOLE SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
Drug Labeling Information
RECENT MAJOR CHANGES SECTION
RECENT MAJOR CHANGES
Warnings and Precautions, Fundic Gland Polyps (5.10) 06/2018
Warnings and Precautions, Fundic Gland Polyps (5.10) 06/2018